All for Joomla The Word of Web Design
February Friday

Conditions are created to try to start the trial with the vaccine candidates Soberana 01 and Soberana 02 in children and teenagers by the end of February, informed Doctor of Science Vicente Vérez Bencomo, general director of the Finlay Vaccine Institute (IFV).

HAVANA, Cuba, Jan 27 (ACN) Cuban vaccine candidates Soberana 01 and 02, developed by the Finlay Vaccine Institute (IFV), are advancing their clinical trials at an accelerated pace in view of the global emergency decreed by the COVID-19 pandemic.

Among the main modifications made to the Cuban protocol for the clinical management of patients with COVID-19 is to treat patients classified as high-risk sufficiently in advance and to do so in a differentiated manner by means of intensive surveillance.

The Cuban ministry of foreign affairs (MINREX by its Spanish acronym) posted today on Twitter that a group of eleven doctors and four laboratorians are already in Barbados to complete the brigade of the Henry Reeve contingent that supports the work of confronting the COVID-19 pandemic in that Caribbean nation.

More Articles ...